Clinical Trial Update: Safety, Tolerability and Efficacy of ISIS-GCCRRx in Type 2 Diabetes [Phase 2]

View source ↗

Summary

This document reports the completed Phase 2 trial evaluating safety, tolerability, and efficacy of ISIS-GCCRRx in adults with Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• ISIS-GCCRRx

Snippet

Sponsor: Ionis Pharmaceuticals, Inc. | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED